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1. Introduction 
Episodes of hypoxia and hypercapnia occurring during apneas significantly dilate blood 
vessels in the brain (both hypercapnia and hypoxia are potent stimuli of cerebral blood 
vessels dilation - Guyton, 2005). This results, together with a concomitant increase of mean 
arterial pressure, in average blood flow increase in the cerebral vessels. Studies in healthy 
volunteers (Przybylowski, 2003) have shown that episodes of breath apneas cause an 
increase of cerebral blood flow compared with resting conditions (43% on average). 
Following an episode of apnea,  hyperventilation (with normoxia and hypocapnia) 
significantly decreases flow in the middle cerebral artery as compared to quiet breathing by 
20% (Przybylowski, 2003). In normal subjects sleep reduces the vasodilatation response to a 
hypoxia (Meadows, 2004). A number of different mechanisms triggered during sleep apneas 
can influence the blood flow in the brain. The increase in intracranial pressure, together with 
a negative pressure in the chest, may reduce the perfusion of the brain (Jennum, 1989). More 
frequent significant carotid artery stenosis (Silvestrini et al, 2002; Nachtmann et al, 2003) and 
flow disturbances in the intracranial arteries (Behrens et al, 2002; Nachtmann et al, 2003) 
were found in patients with sleep-disordered breathing as compared with a population of 
healthy controls. There was also found that: cerebrovascular autoregulation  reserve and 
hypercapnia triggering cerebral blood vessels dilatation are reduced in patients with 
obstructive sleep apneas as compared with the control group (Balfors, 1994). Similarly, 
studies of cerebral blood flow autoregulation in patients with sleep disordered breathing 
show impaired and delayed expansion of cerebral blood vessels in response to hypoxia 
(Urbano, 2008). Short-term mechanisms, associated with airway obstruction and hypoxia 
during sleep, are of paramount importance in the pathophysiology of cerebral circulation 
disorders and ischemic stroke. During obstructive apnea there is a temporary increase in 
blood flow through the brain vessels  due to hypoxia and hypercapnia, but this increase is 
smaller than that of healthy people. Hyperventilation which follows the apnea causes 
hypocapnia and normoxia with significant reduction of blood flow through the brain 
vessels. Obstructive sleep apnea promotes a substantial fall in cerebral blood flow (Culebras 
et al, 2004; Netzer et al, 1998). It seems that short-term mechanisms, associated with apnea 
during sleep, underlie the observed periodicity of brain ischemic stroke occurrence during 
the day and more frequent prevalence of ischemic stroke in the early morning hours 
(Mohsenin, 2003; Yaggi, 2003). 
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The patomechanisms described above, triggered  during obstructive apneas in sleep, foster 
the development of several cardiovascular diseases, including stroke. One should be aware 
of highly complex mechanism of formation and interaction between apneas  and coexisting 
metabolic pathological disturbances such as obesity, impaired glucose and lipid metabolism 
and impaired endothelial functions in cerebrovascular disorders. These patomechanisms 
often triggered or aggravated by apnea initiate a vicious cycle of pathological metabolic 
disorders, vascular and structural, that start or grow an existing cerebrovascular pathology. 
2. Sleep-disordered breathing (SDB) in patients with ischemic stroke 
2.1 Sleep-disordered breathing (SDB) as a risk factor for ischemic stroke 
The first controlled study of sleep related breathing disorders in cerebrovascular diseases 
were carried out in the 80s. They concerned the snoring as a risk factor for ischemic stroke. 
The first studies were published by a group of Palomaki (Partinen et al, 1985). They 
compared the incidence of snoring in 50 men with ischemic stroke with a control group. The 
study was retrospective with use of a standardized questionnaire. Patients were divided 
into groups of regularly snoring (every night), often and seldom. Polysomnographic studies 
were not performed. It was shown that the relative risk of ischemic stroke is 10.8 times 
higher in regular snorers as compared with not snoring patients. Further results of these 
investigators have shown that snoring is independent of other risk factor for ischemic stroke 
(Palomaki 1989, 1991). Results of other studies on snoring as a risk factor of ischemic stroke, 
show an increased relative risk of stroke in snoring  people (Koskenvuo, 1987). The largest 
cohort study of over 70 thousands  women (Nurses Health Study), showed an increased risk 
of ischemic stroke in regularly snoring women (risk ratio - RR 1.88) and irregularly snoring 
women (RR 1.60) (Hu, 2000). It should be emphasized that the cited studies were done with 
the use of different questionnaires. Both the design of different survey questions, the lack of 
clear criteria for classification of patients as regularly, often and rarely snorers in different 
studies, and the self- assessment of patients (some snoring patients are not aware of it) can 
cause false results. The interpretation of these results  should be cautious (Harbison, 2000). 
More recent studies (Davies, 2003) did not show an increased risk of ischemic stroke among 
snoring men but excessive daytime sleepiness which is  associated with an increased risk of 
ischemic stroke with a relative RR = 3.07 (Davies, 2003). 
In recent years a well-designed studies, with large number of participants, were published 
on the impact of snoring in other vascular diseases. It has been found,  that snoring has 
negative effect on the incidence, clinical course and mortality of myocardial infarction 
(Janszky, 2008). In women with type II diabetes snoring increases the risk of hyperlipidemia 
and increases levels of triglycerides (Williams, 2007). Snoring also increases the risk of 
diabetes (Al-Delaimy, 2002). Snoring, regardless of other risk factors, increases the incidence 
of carotid atherosclerosis (Lee, 2008). Recent studies (Davies, 2003), however, do not prove 
that snoring is a direct risk factor for ischemic stroke. A series of new reports indicate the 
importance of snoring in the development of risk factors for cerebrovascular diseases 
(Williams, 2007; Lee, 2008). Snoring, especially loud and habitual, can indirectly contribute 
to the development of ischemic stroke. 
The first studies concerning  the sleep-disordered breathing  in patients with ischemic 
stroke, with a quantitative assessment of respiratory dysfunction, were conducted in the 90s. 
It was shown that among 47 patients with ischemic stroke 72% have breathing problems 
during sleep (defined as AHI> 10), 53% of patients in this group have had AHI> 30, and 30% 
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of patients have had AHI > 40 (Good 1996). Mohsenin and Valor (1995) showed that, among 
patients with ischemic stroke SDB (AHI> 10) occur in 80% of patients. Another studies 
(Bassetti, 1996, 1997, 1999), conducted on  128 patients with ischemic stroke and 28 in the 
control group, showed the incidence of SDB (AHI> 10) in 62% of patients with ischemic 
stroke, compared with 12,5% in the control group. It has been also shown that the incidence 
of apneas is similar and significantly higher in patients with ischemic stroke and TIA than in 
the control group (Bassetti, 1996). These results suggest that sleep-disordered breathing is  a 
risk factor for ischemic stroke, rather than its consequence. 
Similar results for sleep-disordered breathing in patients with ischemic stroke and TIA were 
obtained in the group of 161 patients (Parra, 2000). The incidence of sleep-disordered 
breathing  in the group with ischemic stroke was 74.5%, while in the TIA group, 61.5%. 
Another study (Wessendorf, 2001) have shown the incidence of apnea during sleep in 44% 
of patients with ischemic stroke, obstructive apneas were the most prominent type of SDB - 
94%, central apneas occurred in 6% of patients. Turkington (2002) observed presence of SDB  
(AHI> 10) in 61% of patients with ischemic stroke. In other studies (Harbison, 2002), the 
incidence of sleep-disordered breathing in patients with acute stroke was 94% and 
decreased during hospitalization to 72% within 6 weeks after stroke. Results presented by 
Iranzo (2002) show that SDB (AHI> 10) in the first night after the stroke occurred in 62% of 
patients. Another study (Kaneko, 2003) showed sleep-disordered breathing in 72% of 
patients with ischemic stroke. A prospective study of 120 patients with excessive day 
sleepiness have shown the relationship between the severity of obstructive apneas and 
hypopneas in patients in the first day of stroke and the clinical course and functional 
capacities, measured using the Barthel scale (Turkington, 2002). Obstructive apneas and 
hypopneas were also associated with increased probability of death and disability after 
stroke (Turkington, 2004). Another study assessed the occurrence of sleep-disordered 
breathing in 139 patients with ischemic stroke within the first three days of stroke, 
comparing characteristics of the strokes that occur at night and during the day. It was found 
that strokes occurring at night were associated with higher risk of SDB prevalence  
(RR = 2.62) compared with strokes occurring during the day. The authors suggest 
pathophysiological association between apneas during sleep and nocturnal strokes 
(Martinez-Garcia, 2004). Another studies evaluated the relationship between arterial blood 
pressure values  after stroke and sleep-disordered breathing and prognosis after stroke. It 
was found that sleep-disordered breathing is  associated with elevated nocturnal arterial 
blood pressure and the lack of nocturnal arterial blood pressure decrease (non dippers). 
There was little correlation between the severity of neurological symptoms, clinical course 
(degree of disability assessed with Barthel scale) and the severity of apnea (Selic, 2005). A 
much larger relationship occurred between nocturnal blood pressure abnormalities and the 
severity of the clinical course of stroke (Selic, 2005). The lack of nocturnal arterial blood 
pressure decrease (non dippers), however, is associated with sleep-disordered breathing 
and increased activity of sympathetic nervous system. Prospective study of 102 patients 
with ischemic stroke and sleep-disordered breathing showed significantly higher risk of 
ischemic stroke in patients with AHI> 10 (RR = 3.5), regardless of other risk factors 
(Dziewas, 2005). Prospective, cohort study ( follow-up of 3.4 years ; 1022 patients diagnosed 
with obstructive apneas and hypopneas - 68% of the total population), showed a 
significantly higher risk of stroke or death (RR = 1.97, p = 0.01)  in patients with sleep-
disordered breathing (AHI> 5) compared with the control group regardless of other risk 
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factors  (age, sex, BMI, arterial hypertension, atrial fibrillation and lipid disorders)  (Yaggi, 
2005). Correlation studies show a trend related to the higher risk of ischemic stroke and 
death in patients with more advanced sleep-disordered breathing (Yaggi, 2005). Patients with 
AHI <35 and AHI> 35 had a relative risk ratios respectively 1.74 and 3.3. Another prospective 
study of stroke risk in patients with sleep-disordered breathing based on a cohort of Wisconsin 
(Wisconsin Sleep Cohort Study, 1121 patients without SDB and 1475 patients with SDB (AHI> 
5), showed significantly higher incidence of ischemic stroke in patients with advanced apneas 
(AHI> 20) compared with control group matched demographically and by other risk factors, 
(Arzt, 2005). The relative risk of ischemic stroke in patients with AHI> 20 in a four-year follow-
up was RR = 4.33 (Arzt, 2005). Most studies conducted so far focused mainly on obstructive 
sleep-breathing disorders in stroke. Most  of the observational studies of patients with 
ischemic stroke indicate a small proportion of the central type apneas (20%) (Bassetti, 1996; 
Parra, 2000; Yaggi, 2003; Kaneko, 2003; Selice, 2005). Respiratory disturbances of the central 
type (Cheyne-Stokes breathing pattern) are observed mainly in patients with ischemic stroke 
with concomitant heart failure (Nopmaneejumruslers, 2005). Another prospective study of 
elderly people (394 pts aged 70 to 100 years) during 6 year follow-up showed significantly 
higher incidence of ischemic stroke in patients with severe obstructive apneas and hypopneas  
(AHI> 30) with a relative risk ratio RR: 2.52 (Munoz, 2006). Further prospective studies 
assessing the mortality of patients with stroke and sleep-disordered breathing in 10-year 
follow-up showed a significantly higher risk of death in patients with obstructive apneas and 
hypopneas  RR = 1.76, compared with the control group. Mortality of patients with central 
sleep apneas was comparable with the control group (Sahlin, 2008). Patients with ischemic 
heart disease and SDB (AHI> 5) were at increased risk of ischemic stroke RR = 2.69 in ten-
years perspective (Valham, 2008). Accordingly, with increasing severity of sleep- disordered 
breathing (AHI <15 and AHI> 15), the risk of stroke was higher  (RR = 2.44 and RR = 3.56).  
2.2 Sleep-disordered breathing in patients in the acute phase of ischemic stroke 
Sleep-disordered breathing occurs in 30 to 90% of patients in the acute phase of ischemic 
stroke. SDB can be divided into two types - central apneas and obstructive hypopneas and 
apneas. In the acute phase of ischemic stroke obstructive apneas  are predominant - (Parra, 
2000; Yaggi, 2003; Kaneko, 2003). Central-type apneas occurring in the acute phase of ischemic 
stroke are promoted by  impaired consciousness, brain edema and location of ischemic lesions 
in the medulla. Supine position and dysphagia favor obstructive type apneas. Recently, many 
research groups have sought to determine the relationship between the occurrence, type and 
severity of apnea in the acute phase of ischemic stroke and its outcome. It was found that a 
quantity of central apneas since the onset of disease decreases over time (Parra, 2000; Kaneko, 
2003) while obstructive apneas remain constant in patients with ischemic stroke (Parra, 2000; 
Kaneko, 2003; Harbison, 2002). The next stage of the research was to determine the 
relationship between the number of obstructive type apneas during sleep and clinical 
improvement in patients with ischemic stroke. It was found that the severity of SDB in the 
acute phase of ischemic stroke negatively correlates with the clinical improvement of 
neurological syndrome (Turkington, 2004; Harbison, 2002; Kaneko, 2003). The increased 
number of obstructive type apneas  in the acute phase of ischemic stroke is highly correlated 
with increased mortality in patients with ischemic stroke, especially if the apneas last longer 
than 30 seconds (Turkington, 2004). The severity of apneas in the acute phase of ischemic 
stroke may be regarded as a predictor of poor neurological improvement  in patients with 
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similar severity of neurological symptoms on admission (Cherkassky, 2003) and duration of 
hospitalization (Kaneko, 2003). Improvement of the functional status of patients (assessed with 
the Barthel scale) after stroke is negatively correlated with the frequency of incidents of sleep-
disordered breathing  (Turkington, 2004; Kaneko, 2003). 
2.3 Treatment of sleep-disordered breathing in patients with ischemic stroke 
Treatment of sleep-disordered breathing in patients with ischemic stroke is strongly 
dependent on the patient's clinical condition (Hui, 2002). It was shown that among patients 
with profound neurological deficit CPAP treatment results are unsatisfactory and do not 
bring the improvement of respiratory parameters (Sandberg, 2001; Wessendorf, 2001). These 
failures are mainly due to poor tolerance of CPAP and poor compliance among patients 
with stroke (Sandberg, 2001; Wessendorf, 2001; Hui, 2002). Results published in 2005 
regarding the introduction of CPAP treatment in patients with first episode of ischemic 
stroke and severe obstructive sleep apneas (AHI> 20) showed a significantly lower 
occurrence of subsequent vascular events (cerebral and cardiac) in patients treated with 
CPAP - 6 , 7% compared with 36% in patients not treated within two months of follow-up 
(Martinez-Garcia, 2005). Other authors did not observe statistically significant benefit from 
the introduction of CPAP treatment in stroke patients with severe obstructive sleep apneas 
(AHI> 30) (Hsu, 2006). Further prospective study on 449 patients with mild and severe 
OSAS and CPAP treatment, showed significantly lower risk of cardiovascular event, 
including stroke (Buchner, 2007). Therapy of patients with severe obstructive sleep apneas  
and arterial hypertension is postulated as a primary prophylaxis of ischemic stroke 
(Goldstein, 2006). Recent prospective study in 223 in stroke patients with concomitant 
obstructive sleep apneas  treated with CPAP have reported that treated patients have 
reduced risk of death compared with not treated in 5-years follow-up (Martinez-Garcia, 
2009). It should be noted that the failure of CPAP treatment is usually the result of a difficult 
cooperation and intolerance of treatment in patients after ischemic stroke. Although there 
are discrepant reports in the literature, the method of CPAP treatment appears to be 
effective in preventing further stroke incidents and reduces the risk of death if there is good 
tolerance of this type of treatment. These results should not limit the interest of researchers 
in the problem of obstructive sleep apnea in stroke patients. There are several recognized 
methods of prevention and treatment of sleep-disordered breathing, which can be used 
successfully in patients with a history of ischemic stroke. These methods include weight 
reduction, improving sleep hygiene - proper sleep position, avoiding the supine position, 
avoiding use of alcohol before bedtime, and very important issue - limitation of the use of 
sleeping pills, particularly the group of benzodiazepines, which may  lead to depression of 
central respiratory center and worsen SDB. Surgical treatment has a prominent place in the 
treatment of SDB. Correction of the anatomical defects of nasopharynx results in many 
patients in reduction of the number and severity of obstructive sleep apneas. It is important 
among stroke patients to select a group with sleep-disordered breathing because of a  
double benefit - diagnostic and therapeutic, as it allows  to modify on of the risk factor-SDB  
in these patients. 
3. Sleep-disordered breathing disorders in neurological diseases 
Respiratory disorders in patients with neurological diseases may be a result of damage to 
different parts of the respiratory rhythm generator and controlling structures responsible for 
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generation of respiratory movements (neuromuscular disorders). Vascular damage to the 
respiratory center may lead  to central respiratory disturbances. Neurodegenerative disease 
can damage the respiratory center (Cormican, 2004), as well as demyelinating lesions (Auer, 
1996) located within the respiratory center. Damage of the axons projecting from respiratory 
center to spinal cord ǂ-motoneurons (cervical spine trauma, demyelinating plaques in 
multiple sclerosis) can cause respiratory disorders. Damage to the ǂ-motor neurons of the 
spinal cord (amyotrophic lateral sclerosis, post-polio syndrome) leads to respiratory failure 
(Aboussouan, 2005). Similarly, peripheral nerve conduction abnormalities (Guillian-Barre 
syndrome and congenital polyneuropathy) may lead to hypoventilation and respiratory 
failure. Disorders of the neuromuscular transmission (myasthenia gravis, botulinum toxin 
poisoning) and primary muscle disorders (myopathies, muscular dystrophy) can cause 
respiratory disorders. Physiological sleep, especially REM sleep phase, is a period 
vulnerable to the occurrence of respiratory disorders. Often the first sign of respiratory 
failure in the course of neurological diseases is sleep-disordered breathing (Katz, 2009; 
Landon, 2006). Due to the risk of significant respiratory complications, often fatal, in the 
course of certain neurological diseases (amyotrophic lateral sclerosis, glycogenosis type II), 
it is advisable to closely monitor the sleep-disordered breathing among such patients (Bach, 
2004; Birnbaum, 2009). Early detection of sleep-disordered breathing, thanks to the 
possibilities of non-invasive respiratory therapy in the earlier stages of the disease, can 
significantly improve the quality of life of patients and their prognosis (Bourke, 2003; 
Farrero, 2005; Mustfa, 2006; Bourke, 2006; Katz, 2009; Ambrosino, 2009). An interesting fact 
is the presence and influence of breathing disorders in neurological diseases not associated 
in their pathophysiology with respiratory problems. Examples of such diseases include 
Alzheimer's disease, Parkinson's disease and epilepsy. Sleep-disordered breathing can often 
worsen the course of these diseases. The main group of neurological disorders often 
associated with respiratory disorders are neuromuscular diseases. 
3.1 SDB in neuromuscular diseases 
Sleep-disordered breathing and respiratory failure are a common consequence of 
neuromuscular diseases. Respiratory failure as a result of the underlying disease is more 
prominent during physiological sleep. Ventilation disorders caused by weakening of 
breathing muscles occur mostly in  patients  at REM sleep stage. Physiological relaxation of 
most of the  body muscles (except diaphragm and oculomotory muscles, Tabachnik, 1981) 
and respiratory drive instability may be the cause of breathing disorders during this phase 
of sleep. It was confirmed in patients with neuromuscular diseases in which blood 
saturation was measured (Bourke, 2002; Katz, 2009). Sleep-disordered breathing in patients 
with neuromuscular diseases can be either of central or obstructive origin. The most 
common type of sleep-disordered breathing  in these patients are central hypoventilation 
and central apneas. 
3.1.1 Motor neuron disease 
Motor neuron disease leads to progressive muscle weakness, including respiratory muscles. 
This results in decreased breathing exertion and hypoventilation (Lyall, 2001). The course 
and severity of respiratory distress affects the clinical course of disease. First of all, bulbar 
form of amyotrophic lateral sclerosis is associated with more rapid development of 
respiratory failure (Hadjikoutis, 2001). Respiratory failure develops in a significant majority 
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of patients with motor neuron disease and is a major cause of mortality. Studies concerning 
sleep disorders and sleep-disordered breathing in motor neuron disease often differ 
significantly. Some studies indicate a significantly higher incidence of sleep-disordered 
breathing in the early stages of the disease (Santos, 2003) and fragmentation of sleep 
(Arnulf, 2000) with the absence or substantial reduction of the duration of REM sleep and 
increased number of arousals (Takekawa, 2001). Sleep-disordered breathing was mainly of 
central origin (Santos, 2003; Bourke, 2002). The severity of respiratory distress tended to 
decrease with time of disease;  in patients with disease lasting less than 1 year  AHI = 23, 
while in patients suffering from more than 2 years AHI = 16. Other studies in the early 
stages of the disease (Kimura, 1999; Ferguson, 1996, David, 1997) do not show significantly 
higher incidence of SDB. Some authors have postulated the relationship between the 
number of apneas during sleep and the clinical course (bulbar form) (Santos, 2003; Kimura, 
1999), others did not observed similar corelations (Ferguson, 1996). The incidence of SDB in 
the early stages of motor neuron disease is estimated from 16 to 76.5% (Bourke, 2002). The 
reasons for such divergent results are due to small study groups of patients (usually not 
exceeding 20 persons), a different methodological approach (polysomnography vs. portable 
devices) and a different stage of the disease and its clinical course. Summarizing the results 
of these studies it is clear that sleep-disordered breathing  in patients with motor neuron 
disease in the early stages of the disease are mostly represented in the form of shallow 
breaths of central origin, arising from the failure of the diaphragm muscle contraction. 
Obstructive disorders are rare and are associated rather with the bulbar form (Bourke, 2002). 
With disease progression the severity of respiratory distress during the day and during 
sleep increases. Most researchers (Kimura, 1999; Bourke, 2002; Bourke, 2003; Santos, 2003; 
Mustfa, 2006; Ozsancak, 2008; Ambrosino, 2009) suggest that early detection of major 
breathing problems during sleep is important and  early qualification for home treatment of 
patients with non-invasive ventilation methods should be performed (Bourke, 2003; Santos, 
2003; Mustfa, 2006; Ozsancak, 2008; Ambrosino, 2009). Along with the improvement of 
technical devices and their increased availability, treatment should be introduced as soon as 
possible (Ozsancak, 2008; Ambrosino, 2009). A number of studies in patients with motor 
neuron disease proved a beneficial effect of using non-invasive ventilation during sleep on 
the quality of life and prognosis (Bourke, 2003, 2006; Moustfa, 2006). Randomized study of 
41 patients with motor neuron disease using non-invasive ventilation during sleep (Bourke, 
2006) showed a significant increase in their quality of life and its prolongation, for an 
average 205 days compared with the control group. The greatest benefit was found in the 
group of patients with less severe involvement of bulbar muscles (Bourke, 2006). Due to the 
nature of SDB in patients with motor neuron disease (mainly central hypoventilation), the 
optimal screening study evaluating the severity of respiratory distress seems to be, both in 
terms of accessibility and sensitivity, overnight oximetry. 
3.1.2 Duchenne muscular dystrophy 
Sleep-disordered breathing in patients with Duchenne muscular dystrophy has a characteristic 
clinical course (Barbe, 1994). In children under 10 years mostly obstructive apneas occur, while 
in older children, with the development of disease, the apneas  of central origin predominate 
(Smith, 1989; Suresh, 2005). The occurrence of obstructive sleep apnea and snoring at a 
younger age is associated with frequent enlargement of the tongue (Barbe, 1994; Suresh, 2005) 
www.intechopen.com
 
Sleep Disorders 
 
102 
and a relatively good function of the respiratory muscles. With age, symptoms of respiratory 
muscle failure develop and lead to  sleep- apneas of central type. The study of 34 patients aged 
from 1 to 15 years showed the presence of daily symptoms of sleep-disordered breathing  in 
64%. Polysomnographic studies have shown obstructive SDB incidence in 31% (median age 8 
years ) and central type SDB in 32% (median age 13 years) (Suresh, 2005). The non-invasive 
ventilation therapy during sleep significantly reduced the number of episodes of breathing 
problems, an average of 11 per hour in 5 years. The authors recommend  polysomnography 
study in patients under 10 years of age with symptoms of sleep-disordered breathing. In 
children above 10 years of age, with early signs of respiratory distress, polysomnographic 
studies must be performed. Treatment  with non-invasive home night ventilation should begin 
as early as possible (Suresh, 2005; Katz, 2009). In children with Duchenne muscular dystrophy 
the best predictor of outcome is the vital capacity, respiratory parameters during sleep are of 
less importance. Recommendations of the American Thoracic Society (2006) include: a history 
of  breathing problems during sleep during each visit, regardless of age, in the case of a patient 
immobilized in a wheelchair polysomnographic evaluation once a year. When 
polysomnography is not feasible it is recommended to control overnight pulse oximetry (Kirk, 
2000) and evaluate arterial gasometry during follow-up visits.  
There are no large systematic studies on sleep -disordered breathing in other types of 
muscular dystrophies. Recently published study analyses SDB in 51 patients with 
facioscapulohumeral muscular dystrophy (Della Marca, 2009). 22 patients had abnormal 
breathing during sleep, 13 of them had obstructive breathing disorders (3 of them required 
the CPAP treatment). In 4 patients during REM sleep hypoxia of central origin were found,  
3 patients had mixed type of respiratory disorders. Other parameters such as BMI, daytime 
sleepiness, and neck circumference did not correlate with the occurrence of sleep-disordered 
breathing. 
3.1.3 Myotonic dystrophy 
Myotonic dystrophy (DM) is the most common neuromuscular disease in the adult 
population (Rowland, 2005). During sleep, individuals with DM may develop hypopneas 
and apneas,  obstructive, central and mixed (Finnimore, 1994; Kiyan, 2009). These disorders 
occur in about half of patients with DM (Labanowski, 1996; Kiyan, 2009). Polysomnographic 
studies show a reduction in the duration and sleep efficiency, increased number of 
nocturnal arousals and time of light sleep (NREM1) and decrease in the time of REM sleep 
(Bourke, 2002). During the day, the rhythm of breathing in patients with myotonic 
dystrophy is irregular while awake, as well as during light sleep. The main problems are 
observed in the REM phase of sleep (Finnimore, 1994). Usually, symptoms of sleep- 
disordered breathing in patients with myotonic dystrophy are far before of signs of 
respiratory distress during the day (Bourke, 2002). Daytime sleepiness in patients with DM 
(assessed with the Epworth sleepiness scale ≥ 10) is felt by about 50% of patients (Laberge, 
2009). Objective tests of daytime sleepiness (MSLT test) show excessive daytime sleepiness 
in 69% of the respondents (Laberge, 2009). Excessive sleepiness correlates with the 
degeneration of serotonergic neurons in the raphe nuclei and central superior nucleus of the 
reticular formation (Ono, 1998). Authors describe the decrease of orexin concentration in the 
cerebrospinal fluid, which indicates a similarity in the pathomechanism of sleepiness in 
narcolepsy and DM (Martinez-Rodriguez, 2003). Due to the progressive nature of the 
disease and mixed character of breathing disorders, respiratory treatment should be 
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implemented only in specialized centers. Sometimes it is necessary to apply a positive 
pressure with a variable values (BiPAP, Auto-CPAP) or additional oxygen therapy. In the 
treatment of excessive sleepiness psychostimulants - metylfenidad and modafinil are used. 
3.1.4 Myasthenia 
Disorders of neuromuscular transmission in the course of myasthenia gravis may cause 
sleep-disordered breathing of central type, especially during REM sleep accompanied by 
declines in blood oxygen saturation (Quera-Salva, 1992; Manni, 1995). The nature of 
respiratory disorders is similar as in other neuromuscular diseases. The severity of 
respiratory distress is associated with disease severity. Sleep-disordered breathing  in 
patients with myasthenia gravis is particularly pronounced before the occurrence of 
myasthenic crisis and precede symptoms of respiratory failure due to exhaustion of the 
respiratory muscles during the night. At that time hypercapnia is the most characteristic 
symptom. Hypoxia and hypercapnia occurring during sleep are often the case of morning 
headaches and progressive fatigue associated with underlying disease. Implementation of 
treatment reduces sleep-disordered breathing (Amino, 1998). There is no clear data to 
evaluate the incidence of SDB in patients with well-controlled myasthenia gravis. Some 
authors have shown an increased incidence of obstructive type of sleep-disordered 
breathing in patients with myasthenia gravis (36% compared to 15-20% expected in the 
population (Nicolle, 2006). Other authors (Prudlo, 2007) found no correlation between the 
occurrence of myasthenia gravis and the occurrence of obstructive breathing disorder 
during sleep. Most studies on the prevalence of SDB in myasthenia gravis was conducted on 
small groups (up to 30 patients). These results should therefore be carefully analyzed. 
Currently it seems that the periods of worsening of the disease are associated with increased 
risk of respiratory distress, while the periods of remission during medical treatment are not 
associated with an increased risk of respiratory disorders during sleep (Prudlo, 2007). 
3.1.5 Glycogenosis type II-Pompe disease 
Pompe disease is a chronic, progressive metabolic myopathy associated with deficiency or 
reduced activity of the acid alpha-glucosidase enzyme. As a result, glycogen storage occurs 
in tissues and impairs their functioning. Depending on the degree of enzyme defficiency 
clinical course of disease may be different. The infantile form is associated with a complete 
lack of the enzyme. Symptoms begin within the first few months of life. The usual 
presenting features are cardiomyopathy and hepatomegaly leading to progressive heart 
failure and respiratory distress. Juvenile and adult forms are due to partial enzyme 
deficiency. Symptoms appear later and the disease has a chronic progressive course 
(Lewandowska, 2008). Adult –onset type of Pompe disease is associated with progressive 
respiratory failure resulting from progressive respiratory muscle weakness (Wierzba-
Bobrowicz, 2007). Patients with adult-onset type of Pompe disease often have sleep-
disordered breathing (Bembi, 2008; Mellies, 2001). These problems usually occur before the 
total respiratory failure. Sleep-disordered breathing is usually present in the REM sleep 
phase in forms of central apneas or hypopneas (Mellies, 2001). Since Pompe is a rare disease, 
few studies have been published regarding the prevalence of SDB in this disease. In one 
study performed in 27 patients with juvenile and adult form, sleep-disordered breathing 
was found in 13 patients, 12 of which had diaphragm weakness (Mellies, 2001). Respiratory 
disorders: hypopneas and apneas, occurred primarily during REM sleep and correlated with 
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decreased tidal volumes, as measured by spirometry during the day. In some patient 
overnight non-invasive mechanical ventilation were initiated (Mellies, 2001). 
Recommendations of treatment and diagnosis of Pompe disease suggest  control 
polysomnography study and initiation of respiratory treatment as early as possible in 
patients with significant SDB (Bembi, 2008). 
4. Neurodegenerative diseases of the central nervous system and SDB 
4.1 Alzheimer disease 
Searching for links between Alzheimer's disease and sleep-disordered breathing has already 
started in the eighties. Cognitive deficits observed in individuals with SDB was seen as a 
preliminary stage in the development of dementia. Cognitive deficits in individuals with 
impaired respiratory function were found on both verbal, spatial and executive functions as 
well as short-term memory (Naegele, 1995; Alchanatis, 2005). A number of 
pathomechanisms may contribute to cognitive impairment in patients with respiratory 
disorders. The important part play episodes of hypoxia and subsequent oxidative stress 
resulting in impaired cholinergic transmission in the central nervous system (Gibson, 1981; 
Shimada, 1981). Another pathomechanism may be associated with changes in cerebral blood 
flow, observed during sleep -significant hypoperfusion after an episode of apnea. Studies 
using magnetic resonance spectroscopy showed a decrease in metabolism in the frontal 
lobes in people with severe respiratory problems during sleep (Alchanatis, 2004) and a 
decrease in metabolism in the white matter (Kamba, 1997). However, biochemical studies, 
concerning the biochemical markers of neuronal damage (S-100ǃ protein), showed no 
significant differences between patients with impaired breathing during sleep and the 
control group (Jordan, 2002). Homocysteine levels did not differ in patients with apneas 
compared with the control group (Svatikova, 2004). The study of magnetic resonance and 
computed tomography show damage to white matter in patients with apneas (Kamba, 2001; 
Macey, 2006) and reduction of the total intracranial brain volume (O'Donoghue, 2005). 
Another argument in favor of the relationship between dementia and apneas was the 
discovery of frequent occurrence of apolipoprotein genotype ApoE4 in people with sleep 
apneas (Kadotani, 2001; Gottlieb, 2004). There were several studies conducted on the effects 
of sleep apnea treatment on improvement of cognitive functions. In most studies a positive 
effect of introducing CPAP therapy was found on improvement of cognitive functions 
(Feuerstein, 1997; Bliwise, 2002; Zimmerman, 2006). It was also observed a beneficial effect 
of donepezil treatment on reducing the number of apneas during sleep and improvement of  
sleep architecture (Moraes, 2008). The degree of cognitive impairment observed in patients 
with sleep-disordered breathing, however, is significantly lower and more slowly 
progressive than in those with Alzheimer's disease (Bliwise, 2002). Daytime sleepiness, 
which is a symptom of respiratory distress has a significant impact on cognitive impairment 
(Feuerstein, 1997). More and more evidence points to a potential relationship between 
vascular dementia and sleep-disordered breathing. Early studies showed a significantly 
higher incidence of respiratory distress in patients with vascular dementia (Hoch, 1986; 
Bliwise, 1989). The authors also showed a correlation between the severity of respiratory 
disorders and dementia (Reynolds, 1985). These studies, however, were performed on small 
groups of patients (up to 30 our participants). Newer studies show a similar incidence of 
sleep-disordered breathing in patients with Alzheimer's disease as in the general population 
of similar age (Bliwise, 2002). However, vascular dementia associated with lacunar strokes 
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and damage to white matter, occurs more frequent in patients with obstructive sleep apneas 
(Bliwise, 2002; Matthews, 2003). 
4.2 Parkinson's disease 
Parkinson's disease is associated with many sleep disorders which include excessive 
daytime sleepiness, insomnia, abnormal sleep architecture, restless legs syndrome and sleep 
disorders associated with REM sleep stage (Dhawan, 2006; Postuma, 2009). It was thought 
that excessive daytime sleepiness is associated with concomitant breathing disorders during 
sleep. Most studies did not confirm this hypothesis. Sleep-disordered breathing in patients 
with Parkinson's disease are at a level similar to the prevalence in the population of people 
in middle age and older (Diederich, 2005; Jahan, 2009). The degree of severity of Parkinson's 
disease does not affect the frequency and severity of respiratory distress (Young, 2002). One 
publication noted a higher incidence of mild obstructive breathing disorders during sleep in 
patients with Parkinson's disease compared with controls (Maria, 2003). Parkinson's disease 
patients  who present with symptoms of disordered breathing during sleep should be 
performed diagnostic tests  and the treatment should be implemented immediately. It is 
known that excessive daytime sleepiness, cognitive impairment and depressive reactions, 
caused by sleep-disordered breathing, may exacerbate the non-motor symptoms of the  
Parkinson’s disease (Monaca, 2006). 
4.3 Multiple system atrophy (MSA) 
In the course of the multiple system atrophy a number of types of SDB may occur (Gilman, 
2003). Obstructive (Munschauer, 1990; Glass, 2006) central (Glass, 2006), and mixed 
disorders of breathing pattern (Guilleminault, 1981) were found. Respiratory disorders and 
respiratory failure may be the first sign of disease. Glass and colleagues (2006) described 6 
cases of MSA beginning with respiratory disturbances. Leading respiratory symptoms were 
excessive daytime sleepiness, laryngeal stridor during sleep, and dyspnea on exertion. 
Polysomnographic studies have shown co-existing obstructive disorders associated with 
laryngeal stridor (caused by paralysis of vocal cords) and the numerous apneas and 
hypopneas of central type. Patomechanisms which links MSA with respiratory problems, 
concern both neural control of breathing rhytmogenesis and respiratory airways. It has been 
shown in postmortem studies reduced excitatory projection from the thalamus (behavioral 
respiratory rhythm drive) to the dorsal inspiratory neurons (Gilman 2003) and a significant 
loss of neurons in the brainstem chemoreceptive neurons (metabolic respiratory drive) 
(Benarroch, 2007). Loss of serotonergic neurons that stimulate the nucleus ambiguous, 
observed in MSA (Weston, 2004), causes weakening of negative throat pressure reflexes and 
may be responsible for laryngeal stridor and obstructive sleep apneas (Bennaroch, 2007). 
The loss of dopaminergic neurons in the periventricular  gray matter, probably responsible 
for the maintenance of wakefulness, can affect both the respiratory rhythmogenesis, as well 
as excessive daytime sleepiness (Bennaroch, 2009). 
5. SDB in epilepsy 
The increased incidence of seizures during the night has been known for a long time. 
Mechanisms associated with the generation of epileptic seizures during sleep are not fully 
understood. It has been suggested there are several mechanisms of pathological 
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synchronization of brain bioelectrical activity, triggered by physiological stages of sleep 
(Gigli, 1992). The phases of sleep in which there is greatest risk of seizures include the 
phases associated with a higher probability of awakening - mainly phase I and II NREM 
sleep type. Phase of sleep associated with EEG desynchronization - REM is characterized by 
a lower risk of seizures. The probability of awakening during sleep increases the risk of 
seizure in the case of idiopathic generalized epilepsies (Bonakis, 2009). A similar mechanism 
was proposed in focal and secondarily generalized seizures (Manni, 2005). Also in these 
types of epilepsy light sleep phase (I and II NREM) may initiate abnormal synchronous 
epileptic discharges. The EEG patterns associated  with arousal  (K complexes) trigger 
pathological EEG hypersynchrony in the second phase of NREM sleep. Seizure during sleep 
is associated with the interruption of the continuity of sleep and disorder of its architecture. 
Seizure, both partial (Bateman, 2008) and generalized (Seyal, 2009), can cause apnea of 
central origin. It is probably due to the short-term disturbances of respiratory 
rhythmogenesis  during sleep  by hypersynchronic epileptic discharges. The effects of sleep-
apnea during seizures, are prolonged hypoxia with a decrease in blood oxygen saturation to 
58% and a significant hypercapnia and acidosis (Seyal, 2009). The mechanism of respiratory 
arrest, and neurogenic pulmonary edema associated with asystole are some of the 
hypothetical mechanisms of sudden unexpected death in epilepsy (SUDEP) (Nashef, 2007; 
So, 2008; Jehi, 2008; Pezzela, 2009). Descriptions of near  SUDEP cases during 
polysomnographic studies indicate sleep apnea as an important part of the clinical picture 
(So, 2000; Trotti, 2009). The pathogenesis of SUDEP is probably associated with the diving 
reflex mechanisms, generated during apnea (So, 2008) followed by significant bradycardia 
to asystole and a significant increase in systemic blood pressure, which significantly 
increases the afterload and metabolic demands of myocardium. In literature there are two 
cases of patients in whom obstructive sleep apnea caused changes in the EEG and cerebral 
hypoxia, which in one case ended in death, and in the second with transient encephalopathy 
(Dyken, 2004). Animal model of SUDEP proves that central apnea and myocardial ischemic 
changes should be considered as the main patomechanisms of death in the course of a 
seizure (Johnston, 1997). The relationship between sleep-disordered breathing and epilepsy 
also revealed a higher incidence of obstructive sleep apneas in patients with epilepsy 
compared with the general population matched for age. In various studies, the incidence of 
sleep-disordered breathing is estimated between 5% and 63% in patients with epilepsy 
(Malow, 1997; Malow, 2000; Beran, 1999; Weatherwax, 2003; Malow, 2003, Hollinger, 2006). 
Higher incidence of obstructive apneas and hypopneas was  found in patients with drug-
resistant epilepsy (Malow, 2000). The co-existence of idiopathic epilepsy and obstructive 
sleep apneas was also observed in the elderly population (Chihorek, 2007). In the cited 
paper the authors suggest that the increase in the number of new cases of idiopathic 
epilepsy in the elderly is associated with an increased incidence of sleep-disordered 
breathing in these patients. A number of studies indicate the beneficial effect of treatment 
with CPAP method for reducing the number of seizures (Malow, 2000, Hollinger, 2006; 
Chihorek, 2007; Malow, 2008). Precise pathomechanisms linking apnea with seizure are 
unknown. There are several reasons that may come up for coexistence of the observed 
higher incidence of seizures with sleep-disordered breathing. Particularly interesting is the 
observation on the significantly higher prevalence of sleep apnea in patients with drug-
resistant epilepsy (Malow, 2000). One of the pathomechanisms may be related to apnea 
hypoxia, which leads to decrease of the available pool of ATP in cortical neurons. It was 
shown that lack of ATP increases the excitability of neurons by the partial depolarization of 
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the cell membrane (Somjen, 2001), which reduces the seizure threshold. Reducing the 
amount of ATP in neurons also causes increase in amplitude of the sodium ion current in 
neurons (Rola, 2004), which may accelerate neuron depolarization and action potential 
generation. Another possible pathomechanism, causing seizures during sleep apnea, is the 
increased number of awakenings and disturbed sleep architecture. Obstructive type of 
respiratory disorders are most common during light sleep (stage I and II NREM sleep), 
during the instability of the respiratory center. In these phases, there are also more 
awakenings. K complexes and sleep spindles which occur in II phase of NREM are 
associated with increased pathological hyper synchrony (Bonakis, 2009). Patients with sleep-
disordered breathing have disturbed sleep architecture. There is an increased time of 
shallow sleep (stage I and II NREM) and the reduction or total absence of REM sleep stage. 
As mentioned above, the NREM sleep, I and Phase II contribute to the occurrence of 
seizures, while desynchronization of bioelectrical activity of the brain in REM stage prevents 
seizures (Seyal, 2009). A patient with severe sleep apneas and disturbed sleep architecture is 
staying longer in the NREM stages, exposed to the induction of seizures, and less in the 
REM stages of sleep associated with lower risk of seizure. Although the consequence of 
these pathomechanisms may be increased risk of seizures in patients with apneas, but 
thanks to the possible treatment a reduction in seizure frequency is observed. Case reports 
noted the reduction of symptoms of sleep-disordered breathing after surgical treatment of 
epilepsy (Földvary-Schaefer, 2008) and the reverse effect of vagal stimulation (Holmes, 2003) 
which indicates a mutual relationship of these two disease entities.  
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